Annual SHA Conference: The Changing Face of Healthcare Technology, Innovation, and Data

Susan Silbermann

President and General Manager

Pfizer Vaccines

Susan Silbermann is President and General Manager of Pfizer Vaccines. In her role, Susan oversees a global business and is responsible for the commercial development of a visionary pipeline portfolio of preventative and therapeutic vaccines to address unmet medical needs and treat serious or life-threatening conditions.

Susan leads a team that partners with government and global civic organizations to maximize PfizerÔÇÖs impact on public health. Pfizer is proud to collaborate with Gavi, the Vaccine Alliance, as we have a shared goal ╠ ÔÇ£to protect the worldÔÇÖs most vulnerable children through a sustainable vaccine program.ÔÇØ Through this collaboration, Pfizer contributes to GaviÔÇÖs goal of immunizing a further 300 million people from 2016 to 2020.

Prior to this position, Susan was the regional president of Latin America within PfizerÔÇÖs Emerging Markets Business Unit. In this role, she managed PfizerÔÇÖs pharmaceutical operations in a diverse market with more than 20 countries, each with varying health needs and priorities. Throughout her nearly 30-year career at Pfizer, Susan has held numerous leadership positions in Marketing, Commercial Development and General Management in the U.S. and international markets. She holds a seat on the International Federation of Pharmaceutical Manufacturers & Associations Vaccine CEO Steering Committee. In addition, Susan serves on the boards of advisors for Catalyst Inc., a nonprofit organization that promotes inclusive workplaces for women, and on the corporate advisory board for the Johns Hopkins University Carey Business School ╠ ÔÇ£Where business is taught with humanity in mind.ÔÇØ Susan has a B.S. in biology and French from Tufts University, and a joint M.B.A./M.A. degree in international business and French studies from the Stern Graduate School of Business and the Institute of French Studies at New York University.

Shiva Kumar, PhD

Vice President and Chief Strategy Officer

IBM Watson Health

Shiva Kumar is currently the Vice President and Chief Strategy officer of IBMÔÇÖs Watson Health division. His work focuses on developing and implementing strategies and Business Designs for IBM in Healthcare and Life Sciences.

Previously, as the Vice President, Strategy at IBM Corporate, ShivaÔÇÖs work focused on studying Digital Disruption and value migration caused by technology adoption across several industries and domains.

Prior to that, Shiva was the Vice President, Enterprise Performance and Industry Analytics in IBM Research. His work focused on creating Research capabilities atthe convergence of Information Flow, Work Flow, Big Data and Analytics.

As the Vice President of Business Performance Initiatives and Strategy in IBMÔÇÖs Enterprise Transformation organization, ShivaÔÇÖs work focused on improving business performance across IBMÔÇÖs execution units with a particular emphasis on applying Analytics to grow Revenues and Labor Effectiveness.

Before joining IBM at the beginning of 2003, Mr. Kumar was an Associate Principal in McKinsey & CompanyÔÇÖs Stamford Office, where he has worked in the areas of business building related to technology and the use of Analytics to improve business performance. Shiva served clients in many industries as a member of McKinseyÔÇÖs High Tech and Business Building practices.

Mr. Kumar received an M.Sc. degree from the Indian Institute of Technology, Kanpur, India, and a Ph. D. from Yale University, both in Physics. Subsequently, he worked as an Associate Professor of Physics at Yale University. His work there included extensive experience in the design and implementation of large-scale data acquisition and analysis software systems.

Paul Wilder

Chief Information Officer

New York eHealth Collaborative

Paul Wilder is the Chief Information Officer of the New York eHealth Collaborative (NYeC). In this role, Paul has responsibility for all technology assets and products at NYeC. This includes development and operation of New YorkÔÇÖs statewide healthcare bus which securely connects the stateÔÇÖs regionally connected networks of healthcare providers.

These regional networks together with the NYeC bus collectively form the SHIN-NY (Statewide Health Information Network for New York) to provide statewide patient identity matching and medical record routing between providers statewide.

Paul also works with the creation of policy that supports the secure exchange of health records statewide as well as nationally, and with driving the adoption of health information technology for New YorkÔÇÖs healthcare providers in all patient care settings. Paul has nearly two decades of experience in healthcare with a focus on information technologies in various technical, marketing, and management roles.

Geoff Calkins

Vice President, Product Management

Flatiron Health

Geoff is Vice President of Product Management at Flatiron Health, a healthcare technology company focused on accelerating research in oncology, where he oversees all research-related activities across product management and operations.

Prior to joining Flatiron Health, Geoff worked at Massachusetts General Hospital as a data scientist and researcher. He started his career at Bain & Company, with an emphasis on technology and healthcare strategy.

Geoff graduated cum laude from Yale with a Bachelor of Science in Biomedical Engineering.

Josh Gluck

Deputy Chief Information Officer

Weill Cornell Medicine

Josh Gluck is the Deputy Chief Information Officer for Weill Cornell MedicineÔÇÖs Information Technologies & Services (ITS) department. With more than 20 years of experience as an IT executive and architect, Josh leverages his expertise to advance the collegeÔÇÖs mission of education, biomedical research, and patient care by researching and strategically implementing new and emerging technologies. In his role, Josh oversees infrastructure and operations for networking, security, telecommunications, and computing, and supports over 10,000 users in the clinical, research, and administrative fields, ensuring excellent customer service across the institution

Prior to his current role at Weill Cornell, Josh served as the Director of Information Technology at NewYork-Presbyterian Hospital, where he was responsible for computing, storage, database, project delivery, software asset management, and client service operations. He holds a bachelorÔÇÖs degree in Computer Science from New York University (ÔÇÖ00, CAS), as well as a MasterÔÇÖs in Technology Management from Columbia University. Additionally, Josh is a certified Project Management Professional (PMP), and is a member of the Garden State Amateur Radio Association, focusing on disaster and humanitarian relief.

Niloo Sobhani

Corporate Director of Analytics

NewYork-Presbyterian Hospital

Niloo is the Corporate Director of Analytics at NewYork-Presbyterian Hospital (NYP) serving as an executive director of analytics services. She is responsible for the strategic oversight and all aspects of the hospital's reporting and analytics operations including data architecture, data delivery, and insight/analysis services. In this capacity Niloo leads a team of 40 directors, managers, developers, data scientists and analysts.

During her tenure at NYP, Niloo has led the consolidation of all reporting and analytics functions within Information Technology while directing the development and implementation of the hospital's real-time analytics and big data infrastructures. She is passionate about innovation and using analytics to address persistent challenges in the healthcare industry. At NYP she has fostered key data science partnerships and led the creation of predictive models and a mobile notification platform to communicate the risk scores to clinical teams.
NilooÔÇÖs team is also responsible for the development and delivery of the analytics components of the hospitalÔÇÖs population health and value-based payment initiatives.

Prior to her current role at NYP, Niloo was a senior manager in healthcare technology consulting, where she focused on large-scale EMR, Patient Management/Patient Accounting implementations, IT strategic planning, and outsourcing operations. Niloo also spent four years in higher education pursuing her passion for student development and the arts.
Niloo attended Carnegie Mellon University, where she earned a B.S. in Applied Mathematics and a Masters in Public Policy and Management.

Clifford Jones

CEO

AllazoHealth

Clifford is the CEO of AllazoHealth, a company that uses predictive analytics to better solve the problem of medication non-adherence. AllazoHealthÔÇÖs award winning and patent pending AllazoEngine┬« platform forecasts individual patientsÔÇÖ adherence to each of their medications, anticipates how medication adherence interventions will influence those patients, and targets the right interventions to the right patients at the right time. Allazo provides its services both as a stand-alone analytics solution and as a full-service medication adherence solution including intervention delivery. AllazoÔÇÖs solutions cover Stars/HEDIS/QRS/DSRIP/Medicaid metrics as well as programs to reduce medical spend and improve outcomes. Its client base oversees the health of nearly 30 million patients.

Previously Clifford developed CVS CaremarkÔÇÖs award-winning ÔÇ£Pharmacy AdvisorÔÇØ medication adherence program. Earlier in his career,Cliff developed analytics solutions for Boston Consulting Group's health care practice. He graduated from the University of PennsylvaniaÔÇÖs dual-degree Management and Technology program where he studied management, engineering and mathematics. He also studied at Wharton in the Health Care Management MBA program.

Arthur Caplan, PhD

Head of the Bioethics Division

NYU Langone Medical Center

Currently the Drs. William F and Virginia Connolly Mitty Professor and founding head of the Division of Bioethics at New York University Langone Medical Center in New York City.

He is the co-founder and Dean of Research of the NYU Sports and Society Program and the head of the ethics program in the Global Institute for Public Health at NYU.

Prior to coming to NYU he was the Sidney D. Caplan Professor of Bioethics at the University of Pennsylvania Perelman School of Medicine in Philadelphia where he created the Center for Bioethics and the Department of Medical Ethics. Caplan has also taught at the University of Minnesota, where he founded the Center for Biomedical Ethics, the University of Pittsburgh, and Columbia University. He received his PhD from Columbia University.

Caplan is the author or editor of thirty-five books and over 700 papers in peer reviewed journals. His most recent book is The Ethics of Sport, (Oxford University Press, 2016).

He has served on a number of national and international committees including as the Chair, National Cancer Institute Biobanking Ethics Working Group; the Chair of the Advisory Committee to the United Nations on Human Cloning; the Chair of the Advisory Committee to the Department of Health and Human Services on Blood Safety and Availability; a member of the Presidential Advisory Committee on Gulf War Illnesses; the special advisory committee to the International Olympic Committee on genetics and gene therapy; the special advisory panel to the National Institutes of Mental Health on human experimentation on vulnerable subjects, the Wellcome Trust advisory panel on research in humanitarian crises, and the Co-Director of the Joint Council of Europe/United Nations Study on Trafficking in Organs and Body Parts.

He is currently the ethics advisor to DOD/DARPA on synthetic biology, a member of the University of PennsylvaniaÔÇÖs External Advisory Committee for its Orphan Disease Center and a member of the Ethics and Ebola Working Group of the World Health Organization. Dr. Caplan also serves as the Chairperson of the Compassionate Use Advisory Committee (CompAC), an independent group of internationally recognized medical experts, bioethicists and patient representatives which advises Janssen/J&J about requests for compassionate use of some of its investigational medicines.

Caplan is a regular commentator on bioethics and health care issues for WebMD/Medscape, for WGBH radio in Boston and WMNF public radio in Tampa. He appears frequently as a guest and commentator on various other national and international media outlets.

Caplan is the recipient of many awards and honors including the McGovern Medal of the American Medical Writers Association and the Franklin Award from the City of Philadelphia. He was a person of the Year-2001 from USA Today. He was described as one of the ten most influential people in science by Discover magazine in 2008. He has also been honored as one of the fifty most influential people in American health care by Modern Health Care magazine, one of the ten most influential people in America in biotechnology by the National Journal, one of the ten most influential people in the ethics of biotechnology by the editors of Nature Biotechnology and one of the 100 most influential people in biotechnology by Scientific American magazine. He received the Patricia Price Browne Prize in Biomedical Ethics for 2011. In 2014 he was selected to receive the Public Service Award from the National Science Foundation/National Science Board which honors individuals and groups that have made substantial contributions to increasing public understanding of science and engineering in the United States. In May, 2016 the National Organization for Rare Disorders (NORD) honored him with their ÔÇÿRare Impact AwardÔÇÖ.

He holds seven honorary degrees from colleges and medical schools. He is a fellow of the Hastings Center, the NY Academy of Medicine, the College of Physicians of Philadelphia, the American College of Legal Medicine and the American Association for the Advancement of Science.

Sumit Sehgal

CTO Healthcare

Intel Security

Sumit Sehgal is the Chief Technology Officer for the Americas focusing on Healthcare for Intel Security. His primary focus is on identifying needs specific to the healthcare industry from a products and practices perspective that improve customer solution adoption in order to achieve improved healthcare ÔÇ£dataÔÇØ security postures. In addition, Sehgal has leveraged his extensive experience in the Health IT space to identify priorities that are key in helping Intel Security roadmap the next generation of solutions in this space.

Sehgal brings together proven best practices of ÔÇ£sustainableÔÇØ security program design with the ever changing landscape of human factors and technology innovation. Sehgal extracts elements from his research interests pertaining to contextualization of information security data to clinical risk and strives to help organizations design and implement practices that influence behavior to achieve organic buy in to information risk management. In addition, SehgalÔÇÖs areas of research interests include enterprise analytics tie in to traditional SIEM, Workforce generational dynamics and their perspectives on information security risk and finally Nanotechnology.

Prior to his role as CTO, Sehgal served as the Chief Information Security Officer for leading academic medical centers located in Boston Massachusetts and Washington D.C. Sehgal is an alumnus from Milwaukee School of Engineering focusing in Software Engineering and holds multiple industry certifications relating to Information Security program management and auditing.